Current Medical Diagnosis and Treatment 2024 کارنت داخلی(نشر تیمورزاده)

House officers, medical students, and all other health professions students will find the descriptions of diagnostic and therapeutic modalities, with citations to the current literature, of everyday usefulness in patient care.

Internists, family physicians, hospitalists, nurse practitioners, physician assistants, and all primary care providers will appreciate CMDT as a ready reference and refresher text. Physicians in other specialties, pharmacists, and dentists will find the book a useful basic medical reference text. Nurses, nurse practitioners, and physician assistants will welcome the format and scope of the book as a means of quickly referencing medical diagnosis and treatment modalities.

Patients and their family members who seek information about the nature of specific diseases and their diagnosis and treatment may also find this book to be a valuable resource.

NEW IN THIS EDITION OF CMDT

• INNOVATIVE TABLE highlighting the “Year in Review: Key Clinical Updates in CMDT 2021,” individually listed with page numbers and reference citations, for easy access to significant changes in this edition

• New section on SARS-CoV-2 virus and COVID-19 infection

• Extensive revision of the Viral & Rickettsial Infections chapter, including new section on acute flaccid myelitis as well as updates on measles, mumps, and Zika virus

• 140 NEW online images in the Heart Disease, Gastrointestinal Disorders, and Cancer chapters

• Addition of the 2019 European guidelines for treating pulmonary embolism

• New table outlining agents to consider for reversing anticoagulant effect during life-threatening bleeding based on the Anticoagulation Forum and American Society of Hematology 2019 guidelines

• Bedaquiline considered first-line medication for multidrug-resistant tuberculosis

• Lefamulin, a new commercially available medication for treating community-acquired bacterial pneumonia

• New information on the combination of emtricitabine/tenofovir alafenamide as antiretroviral treatment for preexposure prophylaxis among men

• A two-drug regimen, dolutegravir plus lamivudine, included in the top recommended HIV antiretroviral regimens

• Recommendation from the Advisory Committee on Immunization Practices for shared clinical decision-making regarding HPV vaccination for adults aged 26–45 years

• Substantial revision of the Sexual & Gender Minority Health chapter

• Bempedoic acid, a new FDA-approved pharmacologic option for lowering LDL cholesterol in patients who cannot tolerate statins

OTHER NEW?

• FDA approval of various closed loop systems that adjust basal insulin delivery for diabetic patients

• Eculizumab, a newly FDA-approved medication for both myasthenia gravis and neuromyelitis optica

• FDA approval of lasmiditan, a new pharmacologic option that can safely be given to migraine sufferers with cardiovascular risk factors

• The sodium-glucose linked transporter (SGLT) inhibitors slow progression of early diabetic nephropathy in addition to their having cardioprotective effects

• The US Preventive Services Task Force recommendation for hepatitis C screening of asymptomatic adults between ages 18 and 79 years

• FDA approval of adjuvant trastuzumab emtansine for patients with HER2-positive breast cancer with residual disease after standard trastuzumab-containing neoadjuvant therapy

• Data from HER2CLIMB, a phase III trial, expected to lead to FDA approval of a new therapy for breast cancer patients with pretreated HER2-positive advanced disease

• Promising results from phase 3 clinical trials of gene therapy for hemophilia A and B

• Information on bremelanotide, a second FDA-approved medication for hypoactive sexual desire disorder in premenopausal women

• Mepolizumab, newly FDA approved for the treatment of eosinophilic granulomatosis with polyangiitis

OUTSTANDING FEATURES OF CMDT

• Medical advances up to time of annual publication

• Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women’s health, sexual and gender minority health, preventive medicine, and palliative care

• Concise format, facilitating efficient use in any practice setting

• More than 1000 diseases and disorders

• Annual update on HIV/AIDS and other newly emerging infections

• Specific disease prevention information

• Easy access to medication dosages, with trade names indexed and costs updated in each edition

• Recent references, with unique identifiers (PubMed, PMID numbers) for rapid downloading of article abstracts and, in some instances, full-text reference articles.

E-CHAPTERS, CMDT ONLINE, & AVAILABLE APPS